S. Yu

Randomized study comparing nab-paclitaxel with solvent-based paclitaxel in Chinese patients (pts) with metastatic breast cancer (MBC)

Z. Guan, Z. Jiang, M. Hawkins, 2007 .

A meta-analysis of the relationship between lymphatic microvessel density and the survival of patient with colorectal cancer.

Z. Yuan, C. Yang, Q. Zheng, 2013, Lymphology.

EFFICACY AND SAFETY OF PIOGLITAZONE IN TYPE 2 DIABETES: A RANDOMISED, PLACEBO‐CONTROLLED STUDY IN PATIENTS RECEIVING STABLE INSULIN THERAPY

J. Rosenstock, D. Einhorn, K. Hershon, 2002, International journal of clinical practice.

Depo‐medroxyprogesterone in Women on Antiretroviral Therapy: Effective Contraception and Lack of Clinically Significant Interactions

J. Park, S. Cohn, Song Yu, 2007, Clinical pharmacology and therapeutics.

Efficacy of utidelone plus capecitabine versus capecitabine for heavily pretreated, anthracycline- and taxane-refractory metastatic breast cancer: final analysis of overall survival in a phase 3 randomised controlled trial.

P. Sun, H. Pan, X. Wang, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Efficacy, safety and impact on β-cell function of dipeptidyl peptidase-4 inhibitors plus metformin combination therapy in patients with type 2 diabetes and the difference between Asians and Caucasians: a meta-analysis

W. Gao, S. Yu, Q. Wang, 2016, Journal of Endocrinological Investigation.

Phase II study of the efficacy and safety of cisplatin-epinephrine injectable gel administered to patients with unresectable hepatocellular carcinoma.

G. Gores, K. Engelmann, T. Vogl, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Study of the Efficacy and Safety of Cisplat in-Epinephrine Injectable Gel Adminis tered to Pat ients With Unresectable

G. Gores, K. Engelmann, T. Vogl, 2003 .

Human peroxisome proliferator-activated receptor alpha (PPARalpha) supports the induction of peroxisome proliferation in PPARalpha-deficient mouse liver.

R. Costa, F. Gonzalez, M. Rao, 2001, The Journal of biological chemistry.

A phase III study of doxorubicin (A) versus cisplatin (P)/ interferonα-2b (I)/ doxorubicin (A)/ fluorouracil (F) combination chemotherapy (PIAF) for inoperable hepatocellular carcinoma (HCC).

T. Mok, W. Yeo, P. Johnson, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Differential expression of B7-H4, VISTA, B7-H6, HHLA2, IDO-1, PD-L1 and CD8 in EGFR mutant and wild-type lung adenocarcinoma

M. Shi, J. Feng, S. Yu, 2019, Annals of Oncology.